Shares of Sokoman Minerals Corp. (
CVE:SIC -
Get Free Report) traded up 6.1% during mid-day trading on Thursday . The company traded as high as C$0.29 and last traded at C$0.26. 3,643,347 shares were traded during mid-day trading, an increase of 510% from the average session volume of 597,463 shares. The stock had previously closed at C$0.25.
Sokoman Minerals Stock Up 5.3%
The company has a market cap of C$85.46 million, a P/E ratio of -18.45 and a beta of 2.79. The company has a 50 day moving average price of C$0.06 and a 200-day moving average price of C$0.05.
About Sokoman Minerals
(
Get Free Report)
Sokoman Minerals Corp., an exploration-stage company, engages in the exploration of mineral properties in Canada. The company primarily focuses on its portfolio of gold projects located in the province of Newfoundland and Labrador. It has 100% owned flagship Moosehead, Crippleback Lake, and the district-scale Fleur de Lys project near Baie Verte in northwestern Newfoundland.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sokoman Minerals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sokoman Minerals wasn't on the list.
While Sokoman Minerals currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.